-
Aurobindo Pharma rallies after calling off proposed deal to buy 51% stake in Cronus Pharma
The company had entered into binding agreements with Cronus for acquisition of 51% ownership by subscribing to 95,059,963 equity shares
The company had entered into binding agreements with Cronus for acquisition of 51% ownership by subscribing to 95,059,963 equity shares
